| Feature | Print Edition (Legacy) | MIMS PDF (Current) | MIMS Online / Database | | :--- | :--- | :--- | :--- | | | Monthly (static) | Monthly/Sporadic | Real-time (Continuous) | | Portability | High (Pocket) | Medium (Requires Device) | Medium (Requires Connectivity) | | Searchability | Low (Manual Index) | High (Ctrl+F / Find) | High (Advanced Filters) | | Visual Fidelity | High (Print Layout) | High (Fixed Layout) | Variable (Responsive Design) | | Interoperability | None | Low (Copy/Paste) | High (API Integration) |
| Access Method | Description | |---------------|-------------| | | The most reliable way to obtain the current PDF edition. Subscriptions are typically offered by the national MIMS publisher (e.g., MIMS Australia, MIMS UK, MIMS India) and may include both the PDF edition and online access. | | Institutional/library access | Many university libraries, hospital libraries, and medical institutions subscribe to MIMS and may provide access to the PDF edition for their members. Library catalogues often list MIMS holdings with notes on electronic availability. | | Free samples/trials | Publishers occasionally offer a free sample PDF of a past issue for evaluation purposes. These can be found on publisher websites or professional portals. | | Mobile apps | The MIMS mobile app (available for iOS and Android) provides offline access to the drug database after an initial download. While not strictly a PDF, it offers a similar offline‑reading experience and is often preferred by younger clinicians. |
The update schedule for PDF editions varies by country: monthly index of medical specialities pdf
MIMS is a pharmaceutical directory. It doesn't just list drugs; it categorizes them by medical specialty, making it easy for a cardiologist to find heart meds or a dermatologist to find skin creams. 🚀 Why the PDF Version is Trending
MIMS often provides than CIMS and some government formularies, particularly for safety information (contraindications, warnings, adverse effects). However, it is a commercial publication, so its coverage may favour products that are actively marketed in primary care, whereas a national formulary may be more comprehensive for hospital‑only or less profitable drugs. | Feature | Print Edition (Legacy) | MIMS
, which stands for the Monthly Index of Medical Specialities, is a renowned pharmaceutical prescribing reference guide that has been a cornerstone of clinical practice for over half a century. First published in the United Kingdom in 1959 by Haymarket Media Group, it remains an essential tool for healthcare professionals worldwide. Over the years, MIMS has evolved from a monthly print publication into a comprehensive digital ecosystem, but its core function remains the same: to provide concise, reliable, and up-to-date information on prescription medicines.
Can be stored on smartphones, tablets, or laptops, ensuring the database is always at hand. Library catalogues often list MIMS holdings with notes
If you are unable to access a premium MIMS subscription or find a compliant digital copy, several high-quality, frequently updated alternatives provide free or institutional access to prescribing information:
The first MIMS publication appeared in the UK in at a time when the pharmaceutical landscape was far less complex. From fewer than 2,000 drugs in that inaugural edition, MIMS has grown to provide concise listings for more than 3,000 products. For many years the print edition was issued quarterly and distributed freely to all practice‑based GPs, with paid subscriptions available to other professionals. In 2023, the December print issue marked the final quarterly print edition, as the publication moved primarily online, though PDF‑based versions continue to be used by many subscribers.
Antihypertensives, diuretics, statins, and antiarrhythmics.